Progesterone is consistently linked to lower sexual desire in studies that track women’s hormones across the menstrual cycle, but the story is messier than that one-liner suggests. When researchers give progesterone as a supplement in controlled clinical settings, the expected drop in desire often fails to materialize. This disconnect between what happens naturally and what happens in a lab makes the question genuinely interesting and worth unpacking beyond a simple yes or no.
The Menstrual Cycle Evidence
The strongest case for progesterone dampening libido comes from studies that measure women’s hormone levels and desire day by day across the menstrual cycle. Around mid-cycle, when estrogen peaks and progesterone is still low, desire tends to be at its highest. Once ovulation passes and progesterone surges during the luteal phase, desire drops. A study tracking daily salivary hormones found that estradiol positively predicted sexual desire, while progesterone was a significant negative predictor of desire both on the day it was measured and for a day or two afterward. Progesterone statistically accounted for the drop in desire from mid-cycle into the luteal phase, though the earlier rise in desire during the follicular phase could not be fully explained by any single hormone.1PubMed. Hormonal predictors of sexual motivation in natural menstrual cycles
Other cycle-tracking research confirms this pattern. In partnered women, both desire directed toward their partner and desire directed toward other people peaked during the fertile window and hit their lowest point in the luteal phase, when progesterone is dominant.2PubMed. Within-cycle fluctuations in progesterone negatively predict changes in both in-pair and extra-pair desire among partnered women This is not a subtle effect. The luteal-phase dip in desire is one of the more reproducible findings in this area of research.
There is an important caveat, though. When researchers brought women into a lab and measured their physical and subjective arousal in response to erotic video clips at different cycle phases, they did not find significant differences based on where women were in their cycle.3PubMed. Menstrual cycle phase predicts women’s hormonal responses to sexual stimuli Spontaneous desire and arousability in response to stimulation may be different things, and progesterone seems to affect the former more reliably than the latter.
What Progesterone Does in the Brain
Part of the reason desire shifts across the cycle has to do with how progesterone interacts with brain reward circuits. Neuroimaging research has shown that the brain’s reward system is more reactive during the mid-follicular phase, when estrogen is rising and progesterone remains low. In that hormonal environment, the neural machinery that makes things feel motivating and pleasurable runs hotter.4PubMed Central. Menstrual cycle phase modulates reward-related neural function in women Once progesterone rises after ovulation, it appears to dampen that heightened reward responsiveness. This is not a targeted sexual effect; it is a broader shift in how the brain processes motivation and pleasure, and sexual desire gets pulled along with it.
At a more granular level, progesterone receptors are densely expressed in a brain region called the ventromedial hypothalamus, which plays a key role in sexual behavior across vertebrate species. In mice, genetically ablating the progesterone-receptor-expressing neurons in this region dramatically reduced female sexual receptivity.5PubMed Central. Sexually dimorphic neurons in the ventromedial hypothalamus govern mating in both sexes and aggression in males This points to progesterone’s receptors being structurally important for sexual behavior, even though the hormone itself seems to push desire down rather than up in many contexts.
The Paradox in Animal Studies
Here is where things get counterintuitive. In many animal species, progesterone actually facilitates mating behavior rather than suppressing it. The classic example is lordosis, the arched-back posture that signals sexual receptivity in female rodents, which depends on a sequence of estrogen priming followed by progesterone exposure. The hypothalamic circuit that governs this behavior relies on estradiol signaling in one brain region that then modulates activity in the ventromedial hypothalamus, where progesterone receptors are concentrated.6Frontiers in Systems Neuroscience. Integrating Neural Circuits Controlling Female Sexual Behavior In rodents, estrogen sets the stage, and progesterone pulls the trigger for receptive behavior.
An even more striking finding comes from rats treated with synthetic hormones mimicking oral contraceptives. When researchers added progesterone back to these animals, sexual activity actually increased, and so did brain levels of allopregnanolone, a neurosteroid metabolite of progesterone. Blocking the conversion of progesterone into allopregnanolone eliminated the increase in sexual behavior.7PubMed. Decreased allopregnanolone induced by hormonal contraceptives is associated with a reduction in social behavior and sexual motivation in female rats So in at least some contexts, progesterone and its breakdown products can promote rather than inhibit sexual motivation.
This does not necessarily translate directly to humans, but it shows that “progesterone decreases libido” is too simple a statement for the underlying biology. The effect depends on what form progesterone takes (natural versus synthetic), what it gets converted into in the brain, what other hormones are present, and what aspect of sexual behavior you are measuring. Spontaneous desire in a diary study and physical receptivity in a mating context are not the same thing.
What Happens When You Actually Give People Progesterone
Given the consistent menstrual-cycle findings, you might expect that giving women progesterone supplements would clearly reduce their desire. But the clinical trial data tells a different story. In controlled studies, neither 200 milligrams per day of oral progesterone nor 10 milligrams per day of oral medroxyprogesterone acetate (a common synthetic progestin) had any measurable influence on mood or libido in postmenopausal women who were also taking estrogen. Similarly, in pharmacologically hypogonadal women given high-dose vaginal progesterone alone, no significant changes in sexual function were observed.8PubMed Central. Increasing women’s sexual desire: The comparative effectiveness of estrogens and androgens
Why would cycle studies consistently show a negative association while supplementation studies show nothing? One possibility is that in a natural cycle, progesterone rises in concert with a whole cascade of other hormonal changes, and the desire-dampening effect is partly driven by those co-occurring shifts rather than by progesterone alone. Another is that the doses used in clinical trials may not replicate the specific brain-level exposure that occurs naturally. It is also possible that expectation effects and life-context factors play a larger role in daily desire diaries than in controlled lab settings. Whatever the explanation, this gap between observational and interventional findings means the clinical picture is genuinely uncertain.
Hormonal Contraceptives and Desire
Many people encounter progesterone-related libido concerns through hormonal birth control. Combined oral contraceptive pills contain a synthetic estrogen paired with a progestin, and progestin-only methods like the injectable form (DMPA) deliver synthetic progesterone without estrogen. The question of whether these methods lower desire is one of the most frequently asked in reproductive health, and the answer is frustratingly inconsistent.
For the injectable progestin-only method, the evidence is genuinely mixed. Decreased libido is a common complaint among users, and progestins have been observed to reduce interest in sex, but some reviews have concluded that the injectable is unlikely to be associated with changes in sexual function. The research simply has not settled the question in one direction.9PubMed Central. Hormonal Contraceptives, Female Sexual Dysfunction, and Managing Strategies: A Review
For combined pills, a long-standing assumption has been that progestins with anti-androgenic properties are more likely to hurt libido than those with androgenic properties, because androgens support desire. But a study that switched women experiencing pill-related sexual dysfunction to either an androgenic or anti-androgenic progestin formulation found equivalent improvements in both groups, challenging that assumption.10PubMed. Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction When women’s sexual complaints improved regardless of which type of progestin they switched to, the progestin type itself was clearly not the only factor at play.
That said, measurable physiological effects do exist. A lab study comparing women on different pill types against women not on any hormonal contraception found that both types of pill users showed reduced genital arousal responses, with women on anti-androgenic pills showing the most pronounced inhibition. Self-reported rates of vaginal atrophy and arousal disorder were also higher in the anti-androgenic group compared to women not on hormonal contraception.11The Journal of Sexual Medicine. Reduction in genital sexual arousal varies by type of oral contraceptive pill So pill formulation seems to matter for the physiological arousal response even if the subjective desire picture is less clear-cut.
Meanwhile, a comparison of two triphasic formulations containing the same progestin but different estrogen doses found that sexual interest scores did not change significantly from baseline with either formulation.12Contraception. The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest The picture you get from the contraception literature overall is that some women clearly experience lower desire on hormonal methods, some do not, and predicting who will be affected based on the progestin type alone is unreliable.
The Estrogen-to-Progesterone Ratio
One underappreciated factor is that progesterone’s effects on mood and desire appear to depend heavily on the ratio of estrogen to progesterone, not just progesterone levels in isolation. A year-long study of menopausal women receiving different hormone regimens found that the group on low-dose estrogen plus a progestin experienced more negative moods compared to the group on high-dose estrogen without a progestin. But the progestin’s psychological effects were attenuated when the estrogen dose was higher, suggesting that a favorable estrogen-to-progestin ratio can counterbalance progesterone’s negative CNS effects.13The Journal of Clinical Endocrinology & Metabolism. The Impact of Different Doses of Estrogen and Progestin on Mood and Sexual Behavior in Postmenopausal Women Desire and arousal in that study were higher during the weeks women were actively taking hormones compared to the hormone-free week, regardless of which group they were in.
This ratio concept helps explain some of the contradictions in the broader literature. During the luteal phase, progesterone rises sharply while estrogen drops from its mid-cycle peak, creating a low estrogen-to-progesterone ratio. During pregnancy, both hormones soar but progesterone dominates. In hormone therapy, the specific doses chosen create very different ratios. If progesterone’s effects on desire are partly gated by how much estrogen is present to buffer them, then asking “does progesterone decrease libido” without specifying the hormonal context is a bit like asking whether salt ruins food without specifying how much of everything else is in the recipe.
Pregnancy and Declining Desire
Pregnancy offers a natural experiment in sustained, very high progesterone exposure. Progesterone levels climb throughout gestation, reaching concentrations many times higher than anything seen in a normal menstrual cycle. A review of the relationship between pregnancy and sexual desire concluded that the hormonal fluctuations occurring during pregnancy are reliably associated with progressive decreases in feelings of sexual desire in the majority of women.14Social Behavior and Personality: an international journal. PREGNANCY AND CHANGES IN FEMALE SEXUAL DESIRE: A REVIEW
It would be tempting to point directly at progesterone as the culprit, but pregnancy involves so many simultaneous changes that isolating any single hormone’s contribution is almost impossible. Fatigue, nausea, body-image shifts, relationship dynamics, physical discomfort, and anxiety about the pregnancy all contribute. The hormonal environment is also far more complex than just progesterone: estrogen, prolactin, oxytocin, and relaxin are all elevated. Pregnancy is consistent with the idea that high progesterone suppresses desire, but it is hardly a clean test of that hypothesis.
What About Men
Progesterone is not exclusively a female hormone. Men produce it in smaller quantities, primarily in the adrenal glands and testes, and it serves as a precursor in the synthesis of other steroid hormones. Earlier research suggested that progesterone inhibits androgen-dependent sexual behaviors in males, but those studies almost exclusively used pharmacological doses far above anything the body produces naturally. That makes the findings less informative about what endogenous progesterone actually does in men’s sexual responses day to day.15PubMed Central. Progesterone and sexual behavior in males
Clinically, high-dose synthetic progestins have been used to reduce sex drive in men convicted of sexual offenses, which speaks to the hormone’s capacity to suppress male libido at supra-physiological levels. But at the modest concentrations circulating in a healthy man, progesterone’s role in day-to-day libido fluctuations is poorly understood. Most research on hormones and male desire focuses on testosterone, and progesterone remains a secondary character in that literature.
Why Individual Responses Vary So Much
One reason the research on this topic can feel contradictory is that individual variation in hormonal sensitivity is enormous. Two women with identical progesterone levels can report very different desire profiles. This likely reflects differences in progesterone receptor density and distribution in the brain, variation in how efficiently the body converts progesterone into neuroactive metabolites like allopregnanolone, and differences in baseline levels of other hormones that interact with progesterone’s effects. Psychological factors, relationship satisfaction, stress, sleep, and medication use all layer on top of the hormonal picture.
The treatment landscape reflects this complexity. For conditions where low desire and hormonal symptoms overlap, such as premenstrual dysphoric disorder co-occurring with sexual dysfunction, the medications approved for one condition can sometimes worsen the other. SSRIs, commonly prescribed for PMDD, are well known for suppressing libido as a side effect. And while medications like flibanserin and bremelanotide target low desire specifically, their interactions with hormonal treatments remain an open question.16PubMed Central. Understanding the Interplay Between Premenstrual Dysphoric Disorder (PMDD) and Female Sexual Dysfunction (FSD) The research has not yet produced clean guidance for managing desire and mood symptoms simultaneously when both are driven by progesterone sensitivity.
If you are experiencing a noticeable drop in desire and suspect your hormonal contraceptive or hormone therapy is the cause, the evidence supports the idea that switching formulations is worth trying, but it does not strongly support choosing a new formulation based solely on the androgenic or anti-androgenic profile of the progestin. The relationship between progestin type and desire is real but unpredictable at the individual level, and trial-and-error with a clinician who takes sexual side effects seriously remains the most practical approach.
Natural Versus Synthetic Progesterone
A distinction that matters but often gets glossed over is the difference between bioidentical progesterone and synthetic progestins. Bioidentical progesterone is chemically identical to what the body produces and can be converted into allopregnanolone and other neurosteroids in the brain. Synthetic progestins like medroxyprogesterone acetate, levonorgestrel, and drospirenone have varying chemical structures, different receptor binding profiles, and may or may not be metabolized into the same neuroactive compounds. Some synthetic progestins interact with androgen receptors, either activating or blocking them, which adds another layer of complexity to their effects on desire.
The rat study described earlier found that natural progesterone restored sexual motivation specifically through its conversion to allopregnanolone.7PubMed. Decreased allopregnanolone induced by hormonal contraceptives is associated with a reduction in social behavior and sexual motivation in female rats A synthetic progestin that cannot be converted along that same pathway would lack this pro-sexual effect. This means lumping all progestational agents together under the umbrella of “progesterone” obscures meaningful pharmacological differences. When someone asks whether progesterone decreases libido, the answer could genuinely depend on which molecule they are talking about. The natural hormone has a dual nature: it may suppress spontaneous desire through one mechanism while supporting aspects of sexual function through its metabolites via another. Most synthetic progestins lack the second half of that equation.